Infectious Diseases Associates
Sarasota, Florida, United States
Diagnostic center in Sarasota, Florida
1425 S Osprey Ave # 1, Sarasota, FL 34239
About Infectious Diseases Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Agouron Pharmaceuticals
3
EMD Serono
2
Bristol-Myers Squibb
1
Glaxo Wellcome
1
Schering-Plough
1
Theratechnologies
1
Triangle Pharmaceuticals
1
ViiV Healthcare
1
Clinical Trials at Infectious Diseases Associates
During the past decade, Infectious Diseases Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
2000-01-01
Completed
75
Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
1999-11-01
Suspended
30
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
1999-08-01
Suspended
350
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
2000-03-01
2000-09-01
Completed
250
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
2000-08-01
Unknown status
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
2000-11-01
Unknown status
624
A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor
2001-08-01
2002-04-01
Terminated
500
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
2004-05-28
2005-09-28
Completed
326
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Infectious Diseases Associates" #1 sponsor was "Agouron Pharmaceuticals" with 3 trials, followed by "EMD Serono" with 2 trials
sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Glaxo Wellcome" with 1 trials sponsored and "Schering-Plough"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
Clinical Trials Conditions at Infectious Diseases Associates
According to Clinical.Site data, the most researched conditions in "Infectious Diseases Associates" are
"HIV Infections" (10 trials), "Lipodystrophy" (2 trials) and "Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome" (1 trials). Many other conditions were trialed in "Infectious Diseases Associates" in a lesser frequency.
Clinical Trials Intervention Types at Infectious Diseases Associates
Most popular intervention types in "Infectious Diseases Associates" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nelfinavir mesylate" (5 trials), "Capravirine" (3 trials), "Lamivudine/Zidovudine" (2 trials), "Abacavir sulfate" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Infectious Diseases Associates
The vast majority of trials in "Infectious Diseases Associates" are
11 trials for "All" genders.
Clinical Trials Status at Infectious Diseases Associates
Currently, there are NaN active trials in "Infectious Diseases Associates".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Infectious Diseases Associates,
2 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Infectious Diseases Associates, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".